Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Mette Vang Larsen, Lars Haukali Omland, Jan Gerstoft, Birgit T. Røge, Carsten Schade Larsen, Gitte Pedersen, Niels Obel & Gitte Kronborg. (2010) Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: A nationwide population-based cohort study. Scandinavian Journal of Infectious Diseases 42:11-12, pages 917-923.
Read now
Read now
Articles from other publishers (18)
Ivana GrgicSnjezana Zidovec LepejMaja M. LunarMario PoljakAdriana VinceIvana Baca VrakelaAna PlaninicKatja SemeJosip Begovac. (2013) The Prevalence of Transmitted Drug Resistance in Newly Diagnosed HIV-Infected Individuals in Croatia: The Role of Transmission Clusters of Men Who Have Sex with Men Carrying the T215S Surveillance Drug Resistance Mutation. AIDS Research and Human Retroviruses 29:2, pages 329-336.
Crossref
Crossref
LASSE VINNER, BIRGITTA HOLMGREN, KRISTOFFER J. JENSEN, JOAKIM ESBJORNSSON, Marie BORGGREN, JULIE L. HENTZE, INGRID KARLSSON, BETINA S. ANDRESEN, GREGERS J. GRAM, HENRIK KLOVERPRIS, PETER AABY, ZACARIAS JOSÉ DA SILVA, EVA-MARIA FENYÖ & ANDERS FOMSGAARD. (2011) Sequence analysis of HIV-1 isolates from Guinea-Bissau: selection of vaccine epitopes relevant in both West African and European countries. APMIS 119:8, pages 487-497.
Crossref
Crossref
Marie Rathcke Lillemark, Jan Gerstoft, Niels Obel, Gitte Kronborg, Court Pedersen, Louise Bruun Jørgensen, Tina Vasehus Madsen & Terese Lea Katzenstein. (2011) Characterization of HIV‐1 from patients with virological failure to a boosted protease inhibitor regimen. Journal of Medical Virology 83:3, pages 377-383.
Crossref
Crossref
Philip A ChanRami Kantor. (2009) Transmitted drug resistance in nonsubtype B HIV-1 infection. HIV Therapy 3:5, pages 447-465.
Crossref
Crossref
Helene Mens, Louise Bruun Jørgensen, Gitte Kronborg, Kristian Schønning & Thomas Benfield. (2008)
Immunological responses during a virologically failing antiretroviral regimen are associated with
in vivo
synonymous mutation rates of HIV type-1
env
. Antiviral Therapy 14:3, pages 413-422.
Crossref
Crossref
Ioanna KousiappaDavid A.M.C. van de VijverIoannis DemetriadesLeondios G. Kostrikis. (2009) Genetic Analysis of HIV Type 1 Strains from Newly Infected Untreated Patients in Cyprus: High Genetic Diversity and Low Prevalence of Drug Resistance. AIDS Research and Human Retroviruses 25:1, pages 23-35.
Crossref
Crossref
Tina Vasehus MadsenNicolai LohseEa Stilling JensenNiels ObelKarin LadefogedJan GerstoftAnn Berith PetersenClaus NielsenLouise Bruun Jørgensen. (2008)
Short Communication:
High Prevalence of Drug-Resistant Human Immunodeficiency Virus Type 1 in Treatment-Naïve Patients in Greenland
. AIDS Research and Human Retroviruses 24:8, pages 1073-1077.
Crossref
Crossref
Wendy P Bannister, Alessandro Cozzi-Lepri, Bonaventura Clotet, Amanda Mocroft, Jesper Kjær, Peter Reiss, Viktor von Wyl, Adriano Lazzarin, Christine Katlama, Andrew N Phillips, Lidia Ruiz & Jens D Lundgren. (2008) Transmitted Drug Resistant HIV-1 and Association With Virologic and CD4 Cell Count Response to Combination Antiretroviral Therapy in the EuroSIDA Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 48:3, pages 324-333.
Crossref
Crossref
Betina S. AndresenLasse VinnerSheila TangKaroline BragstadGitte KronborgJan GerstoftSylvie CorbetAnders Fomsgaard. (2007) Characterization of Near Full-Length Genomes of HIV Type 1 Strains in Denmark: Basis for a Universal Therapeutic Vaccine. AIDS Research and Human Retroviruses 23:11, pages 1442-1448.
Crossref
Crossref
Nicolai Lohse, Louise B Jørgensen, Gitte Kronborg, Axel Møller, Birgit Kvinesdal, Henrik T Sørensen, Niels Obel, Jan Gerstoft, J Gerstat, N Obel, G Kronborg, C Pedersen, CS Larsen, G Pedersen, AL Laursen, B Kvinesdal & A Møller. (2007) Genotypic Drug Resistance and Long-Term Mortality in Patients with Triple-Class Antiretroviral Drug Failure. Antiviral Therapy 12:6, pages 909-918.
Crossref
Crossref
Nicolai Lohse, Niels Obel, Gitte Kronborg, Louise Bruun Jørgensen, Court Pedersen, Carsten Schade Larsen, Birgit Kvinesdal, Henrik Toft Sørensen & Jan Gerstoft. (2005) Declining Prevalence of HIV-Infected Individuals at Risk of Transmitting Drug-Resistant HIV in Denmark during 1997–2004. Antiviral Therapy 11:5, pages 591-600.
Crossref
Crossref
Dunja Z. Babič, Mojca Zelnikar, Katja Seme, Anne-Mieke Vandamme, Joke Snoeck, Janez Tomažič, Ludvik Vidmar, Primož Karner & Mario Poljak. (2006) Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000–2004. Virus Research 118:1-2, pages 156-163.
Crossref
Crossref
M Escoto-Delgadillo, E Vazquez-Valls, M Ramirez-Rodriguez, A Corona-Nakamura, G Amaya-Tapia, N Quintero-Perez, A Panduro-Cerda & BM Torres-Mendoza. (2005) Drug-resistance mutations in antiretroviral-naive patients with established HIV-1 infection in Mexico. HIV Medicine 6:6, pages 403-409.
Crossref
Crossref
Diane L. Hirigoyen & Charles P. Cartwright. (2005) Use of Sequence Data Generated in the Bayer TruGene Genotyping Assay To Recognize and Characterize Non-Subtype-B Human Immunodeficiency Virus Type 1 Strains. Journal of Clinical Microbiology 43:10, pages 5263-5271.
Crossref
Crossref
D. Paraskevis, E. Magiorkinis, A. Katsoulidou, E. Hatzitheodorou, A. Antoniadou, A. Papadopoulos, G. Poulakou, V. Paparizos, C. Botsi, N. Stavrianeas, M. Lelekis, M. Chini, P. Gargalianos, N. Magafas, M. Lazanas, G. Chryssos, G. Petrikkos, G. Panos, T. Kordossis, M. Theodoridou, V. Sypsa & A. Hatzakis. (2005) Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece. Virus Research 112:1-2, pages 115-122.
Crossref
Crossref
Nicolai Lohse, Niels Obel, Gitte Kronborg, Alex Laursen, Court Pedersen, Carsten S Larsen, Birgit Kvinesdal, Henrik Toft Sørensen & Jan Gerstoft. (2005) Declining risk of triple-class antiretroviral drug failure in Danish HIV-infected individuals. AIDS 19:8, pages 815-822.
Crossref
Crossref
Martin Stürmer, Annemarie Berger, Wolfgang Preiser & Hans Wilhelm Doerr. (2005) Kommerzielle Systeme zur Genotypisierung von humanen Immundefizienzviren Typ 1: Vergleich von ViroSeq (Abbott) und TruGene (Bayer). Commercially available assays for genotyping of human immunodeficiency virus type 1: Comparison of ViroSeq (Abbott) and TruGene (Bayer). LaboratoriumsMedizin 29:1, pages 50-62.
Crossref
Crossref
A-M Vandamme, A Sönnerborg, M Ait-Khaled, J Albert, B Asjo, L Bacheler, D Banhegyi, C Boucher, F Brun-Vézinet, R Camacho, P Clevenbergh, N Clumeck, N Dedes, A De Luca, HW Doerr, J-L Faudon, G Gatti, J Gerstoft, WW Hall, A Hatzakis, N Hellmann, A Horban, JD Lundgren, D Kempf, M Miller, V Miller, TW Myers, C Nielsen, M Opravil, L Palmisano, CF Perno, A Phillips, D Pillay, T Pumarola, L Ruiz, M Salminen, J Schapiro, B Schmidt, J-C Schmit, R Schuurman, E Shulse, V Soriano, S Staszewski, S Vella, M Youle, R Ziermann & L Perrin. (2004) Updated European Recommendations for the Clinical Use of HIV Drug Resistance Testing. Antiviral Therapy 9:6, pages 829-848.
Crossref
Crossref